Quote | Vera Therapeutics Inc. (NASDAQ:VERA)
Last: | $43.31 |
---|---|
Change Percent: | -3.63% |
Open: | $43.65 |
Close: | $44.94 |
High: | $45.2 |
Low: | $42.56 |
Volume: | 269,789 |
Last Trade Date Time: | 05/09/2024 03:00:00 am |
News | Vera Therapeutics Inc. (NASDAQ:VERA)
2024-05-09 10:38:59 ET More on Vera Therapeutics Vera Therapeutics: Waiting For A Pullback Top 10 best performing biotech stocks of 2024 so far Seeking Alpha’s Quant Rating on Vera Therapeutics Historical earnings data for Vera Therapeutics Fin...
Presented positive 72-week data from the Phase 2b ORIGIN clinical trial, setting a new standard in IgAN with no loss of kidney function over the duration of treatment Topline 96-week data from ORIGIN 2 trial expected in Q4 2024 Pivotal Phase 3 ORIGIN 3 trial estimated to complet...
Message Board Posts | Vera Therapeutics Inc. (NASDAQ:VERA)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $VERA News Article - Vera Therapeutics Completes Patient Enrollment in Phase 2b ORIGIN | whytestocks | investorshangout | 07/06/2022 2:40:53 PM |
whytestocks: $VERA News Article - Vera Therapeutics Announces Closing of Upsized Public Offering of | whytestocks | investorshangout | 02/14/2022 9:30:49 PM |
whytestocks: $VERA News Article - Vera Therapeutics Hosting Key Opinion Leader Webinar on IgA Nephro | whytestocks | investorshangout | 09/09/2021 5:40:58 PM |
Stock_Tracker: Latest Veramark Techs Inc (VERA) Headlines Calero Software is Launched from the Merge | Stock_Tracker | investorshangout | 03/12/2014 4:42:37 AM |
$VERA: Merged with TEM Holdings Inc. for $1.18 | Renee | investorshub | 07/22/2013 11:33:11 PM |
News, Short Squeeze, Breakout and More Instantly...
Vera Therapeutics Inc. Company Name:
VERA Stock Symbol:
NASDAQ Market:
Presented positive 72-week data from the Phase 2b ORIGIN clinical trial, setting a new standard in IgAN with no loss of kidney function over the duration of treatment Topline 96-week data from ORIGIN 2 trial expected in Q4 2024 Pivotal Phase 3 ORIGIN 3 trial estimated to complet...
BRISBANE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on May 1, 2024, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 15,000 shares of Class A co...
2024-05-05 03:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...